+ Role of Industry in Clinical Care, Research, and Education.

Slides:



Advertisements
Similar presentations
Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
Advertisements

Conflict of Interest (COI) Objectives: Provide an overview of financial conflict of interest (FCOI) related to research activities at Gillette Describe.
Conflict of Interest in Physician-Industry Relationships
National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships Rev. 10/21/2014 APGO Interaction with Industry: A Medical.
Marketing to Doctors – Payments for Loyalty Julie Brill Assistant Attorney General Vermont Attorney General ’ s Office Montpelier,
International Seminar on Drug Advertising Canadian Experience Brazilian Health Surveillance Agency and Pan American Health Organization Brasilia, Brazil.
Conflict of Interest. Definition  “A conflict of interest is a situation in which financial or other personal considerations have the potential to compromise.
Module 2 Sealy Center on Aging What kinds of scholarly products can I produce?
Kathleen A. Ream Director, Government Affairs October 1, 2010.
DR EBTISSAM AL-MADI Management of Information in health care organizations.
The Facts About Rising Health Care Costs.
Promoting Objectivity in Research by Managing, Reducing, or Eliminating Conflicts of Interest UT HOP UT HOP The University of Texas at Austin.
Rare Diseases Foundation Céline Hubert Pr Nicolas Lévy
Part 2  In community-based long-term care, the resident may simply need assistance with taking their medications at the right time or with preparing.
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Copyright © 2011 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 4 Health Care Delivery, Quality, and the Continuum of Care.
# Operating Under the New Compliance Environment: Considerations for the Pharmaceutical Industry The Impact of the new Medicare Prescription Drug benefit.
HYPERTENSION The Alabama Department of Public Health’s Hypertension Program.
Role of Industry in Clinical Care, Research and Education Rev 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
VCU School of Medicine Policy on Industry Relations Effective July 1, 2009.
Lukas Steinmann Mexico 10. June 2008 To your health: diagnosing the state of healthcare and the global private medical insurance industry.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
© 2008 Foley Hoag LLP. All Rights Reserved. 1 The New Massachusetts Pharmaceutical & Medical Device Marketing Regulations How to Address and Overcome Likely.
New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.
Nairobi, Kenya June 26, 2013 ROLE OF THE WFH, IN ACHIEVING TREATMENT FOR ALL.
“Delivering Therapeutic Agents” - Marketing and Communication Strategies of Drug Companies Safura Nantogmah.
Patient, health care and pharmaceutical promotion – a critical inventory Hans-Joachim Both Neurologist, member of IPPNW group Berlin mail adress :
Health Care In America From Market Place to Human Right Dr. Peter Mahr PNHP.
+ Conflict of Interest in Physician-Industry Relationships.
David Chelnick The Iron Grip of Pharmaceutical Companies.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
Measuring and Rewarding Physician Performance: A National Movement David S. P. Hopkins, Ph.D. Pacific Business Group on Health Provider Reimbursement Web.
A Focus on CME and Grants Nancy Coddington, PhD Senior Director, Compliance Operations AstraZeneca Pharmaceuticals LP And Terry Hisey Deputy Managing Principal.
Disclosure of Financial Conflicts of Interest in Continuing Medical Education Michael D. Jibson, MD, PhD and Jennifer Seibert, MD University of Michigan.
OUTLINE OF HEALTH CARE PLAN RICHARD R. SCHNEIDER, MD F.A.C.P., F.A.C.C.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Partners Conflict of Interest Policy and Reporting October 11, 2012.
Global Challenges in Cancer Pain S. Lawrence Librach MD,CCFP,FCFP Professor, Department of Family & Community Medicine Sun Life Financial Chair & Director,
1 Continuing Medical Education and Industry Sponsorship The Pharma, Biotech and Device Colloquium Princeton, NJ June 7, 2005 Julie K. Taitsman, M.D., J.D.
Conflicts of Interest Scenarios: Decision Path Norma Houston 2011 Health Directors’ Legal Conference Continue.
Copyright © Harvard Medical School. All Rights Reserved. Outside Activity Report: What Do I Need to Report?
Health Reform: Local Safety Net Implications Karen J. Minyard, Ph.D., Executive Director, Georgia Health Policy Center, Georgia State University.
Sara Lovell, CPCS Education Coordinator Providence Alaska Medical Center.
“Commercial Interest” ● ‘exempt’ entities (per ACCME) ● ‘exempt’ entities (per ACCME) – 501-C non-profit organizations – Government organizations – Non-health.
Ethics Case 1 Remonte. Rivera, K., Sagayaga. Siy. Talan.
FDA Regulatory and Compliance Symposium Industry Collaboration & Interactions with Health Professionals: Can Conflicts of Interest be Properly Managed?
H ⊕ lger Schünemann, MD, PhD Professor and Chair, Dept. of Clinical Epidemiology & Biostatistics Professor of Medicine Michael Gent Chair in Healthcare.
1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 39 The Advanced Practice.
HEALTH INSURANCE PLANS. BACKGROUND INFO Cost is a major concern Health care is over 15% of gross national product Without insurance, the cost of an illness.
Technology of healthcare  BY: seemeka Johnson. Technology of healthcare Doctors now know that genetics play a part in possibly passing on diseases from.
CIS 170 MART Teaching Effectively/cis170mart.com FOR MORE CLASSES VISIT HCA 497 MART Inspiring Minds/hca497mart.com FOR MORE CLASSES.
HEALTH INSURANCE PLANS
Hospitals and Health Systems
Disclosure UK Talking about Transparency.
An Introduction to Health Care and Health Policy in the United States
Alzheimer’s and Dementia: National and Local Advocacy
“Conflicts of Interest”
The Many Careers of Pharmacy
How Available is Health Care?
Disclosure UK Talking about Transparency.
Novel approaches to TB infection control in private general hospitals in Georgia T Gabunia1, I Khonelidze, N Solomonia, T Merabishvili, M Makharadze,
HEALTH INSURANCE PLANS
Conflicts of Interest In the past 2 years I have been an employee of:
Community and Primary Care Grants
Health Information Systems: Functional Capacity
Financial Disclosure Financial Interest / Affiliation
The most popular professions in America
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
The Health Technology Assessment Division of the
Presentation transcript:

+ Role of Industry in Clinical Care, Research, and Education

+ Objectives Understand the role industrial development of medical products plays in the advancement of health care including contributions to clinical care, research, and education Be familiar with the various levels of industry’s support to physicians/medical practice and identify those which lead to risk of conflict of interest

+ Role of Industry in Health Care Advancement Advancement in diagnosis and treatment of disease Continuous development and improvement of drugs and devices Financial support for research Unrestricted funding for educational programs especially CME

+ Contributions to Clinical Care Significant contributions to global health programs Contributions to help meet the Millennium Development Goals Delivery of free or low cost drugs to millions of patients around the globe

+ Contributions to Research Biomedical research expenditures by industry exceed those of the federal government 60% of biomedical research is privately funded 70% of this private funding comes directly from pharmaceutical industry

+ Contributions to Education 37% of clinical departments receive funding for resident and fellowship training 50% of continuing medical education (CME) is funded primarily through educational grants provided by the pharmaceutical industry

+ Contributions to Education CME Support

+ Promotional Expenditures In 2002, an estimate of $21 billion dollars were spent in the United States on pharmaceutical promotions 56% on samples 25% on doctors 12.5% on direct-to-consumer advertising 4% on hospitals 2% on journal ads

+ Support to Physicians/Medical Practice In 2002, pharmaceutical companies spent 11.5 billion dollars to provide physicians with free samples In a survey of more than 3,000 physicians: 78% reported receiving samples 83% received meals 35% received reimbursement for CME expenses 28% received payment for consulting or serving on an advisory board or speakers bureau

+ Conflict of Interest (COI) Definition COI may be defined as any situation in which the individual or corporation is in a position to influence or exploit a professional or official capacity in some way for their personal gain or corporate benefit

+ Risk for Conflict of Interest Industry involvement and support has potential to affect decision making of physicians and lead to treatment practices based on factors other than the scientific merit of the product Interactions with pharmaceutical representatives in educational settings have shown to influence the prescribing practices of physicians

+ Risk for Conflict of Interest Only 1% of physicians believe they are influenced by drug company advertising, while 40% believe other physicians are influenced Medical students are potentially subject to the same influence Many academic centers have placed strong conflict of interest policy in place